Biomarin Pharmaceutical Inc (BMRN)
Receivables turnover
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 3,094,001 | 3,063,608 | 2,950,227 | 2,853,915 | 2,752,809 | 2,588,398 | 2,471,644 | 2,419,226 | 2,310,557 | 2,234,572 | 2,173,095 | 2,096,039 | 2,008,311 | 1,911,709 | 1,879,604 | 1,846,275 | 1,848,588 | 1,916,630 | 1,844,422 | 1,860,435 |
| Receivables | US$ in thousands | 790,266 | 855,855 | 739,177 | 660,535 | 777,547 | 691,232 | 637,163 | 633,704 | 572,498 | 610,222 | 597,913 | 461,316 | 419,622 | 466,507 | 430,147 | 373,399 | 374,937 | 424,419 | 396,097 | 448,351 |
| Receivables turnover | 3.92 | 3.58 | 3.99 | 4.32 | 3.54 | 3.74 | 3.88 | 3.82 | 4.04 | 3.66 | 3.63 | 4.54 | 4.79 | 4.10 | 4.37 | 4.94 | 4.93 | 4.52 | 4.66 | 4.15 |
September 30, 2025 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $3,094,001K ÷ $790,266K
= 3.92
Peer comparison
Sep 30, 2025
Company name
Symbol
Receivables turnover
Biomarin Pharmaceutical Inc
BMRN
3.92
Arrowhead Pharmaceuticals Inc
ARWR
121.55
Regeneron Pharmaceuticals Inc
REGN
2.51